Dr. Rabin’s research has two primary directions.
As the Neuropsychology lead in the Harquail Centre for Neuromodulation, Dr. Rabin’s research characterizes cognitive, behavioural, and psychosocial changes associated with novel neuromodulation strategies. This includes low intensity focused ultrasound (FUS) to open up the blood brain barrier in patients with Alzheimer’s disease, and high intensity FUS to treat severe psychiatric and neurological conditions, such as depression, OCD, and tremor
Another line of her research combines multi-modal neuroimaging (e.g., MRI, PET) with sensitive cognitive measures to better understand modifiable risk factors for Alzheimer’s disease and related dementias. Dr. Rabin was recently awarded a CIHR grant that will investigate risk factors for cognitive impairment in a multi-ethnic cohort, with a specific focus on cardiovascular risk factors and markers of cerebrovascular injury. This research is being carried out in close collaboration with Maged Goubran (co-PI), Sandra Black, and other colleagues at Sunnybrook.